Literature DB >> 27418765

Associations of serum Magnesium levels with diabetes mellitus and diabetic complications.

D Arpaci1, A G Tocoglu1, H Ergenc1, S Korkmaz1, A Ucar1, A Tamer1.   

Abstract

BACKGROUND: Magnesium (Mg) deficiency is a common problem in diabetic patients. Deficiency of Mg may increase the incidence of diabetes mellitus (DM) and occurrence of diabetic complications. In this study, our aim was to evaluate an association between serum Mg level,  glycemic regulation, and diabetic complications. MATERIAL-
METHODS: In this retrospective study 673 diabetic patients were evaluated. According to Mg levels, the patients were divided into two groups; as normomagnesemic patients and hypomagnesemic patients.
RESULTS: Among the patients, 57.8% were men and 42.2% were women. Mean age was 55.6 years and the mean duration of diabetes was 81 ± 86.9 months. The mean glycosylated hemoglobin (HbA1c) was 9.0 ±2.4 % (4.5-18); mean magnesium level was 1.97 ± 0.25 (1.13 to 3.0) mg / dl.  There were 55 patients (8.2%) with diabetic retinopathy and 95 patients (14.1%) with diabetic neuropathy. Five hundred patients (74.3%)  had normoalbuminuria; 133 patients (19. 8%) had microalbuminuria (MA) and 40 patients (5.9%) had overt proteinuria. One hundred and seventy one patients (25.4%) had HbA1c levels equal or below 7%; and 502 patients (74.6%) had HbA1c levels above 7%. There was no statistical difference in age or duration of diabetes between the groups formed according to Mg levels. Although there were no differences between the groups for retinopathy and neuropathy, MA was more common in hypomagnesemic patients (p =0.004). HbA1c levels did not differ between the groups (p =0.243). However there was a weak negative correlation between serum Mg and HbA1c levels (r =-0.110, p =0.004) and also between serum Mg and urine protein level  (r =-0.127, p =0.018).
CONCLUSION: Mg depletion is a common problem in patients with DM. It affects both glycemic regulation and the occurence of complications. Also, poor glycemic regulation affects serum Mg levels. Hippokratia 2015; 19 (2):153-157.

Entities:  

Keywords:  Hypomagnesemia; diabetic complication; poor glycemic control

Year:  2015        PMID: 27418765      PMCID: PMC4938107     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  38 in total

Review 1.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.

Authors:  S F Dinneen; H C Gerstein
Journal:  Arch Intern Med       Date:  1997-07-14

Review 2.  Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.

Authors:  Mario Barbagallo; Ligia J Dominguez
Journal:  Arch Biochem Biophys       Date:  2006-06-12       Impact factor: 4.013

3.  Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria.

Authors:  A Verrotti; F Basciani; F Carle; G Morgese; F Chiarelli
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Magnesium status in diabetes.

Authors:  H M Mather; G E Levin
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

5.  Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.

Authors:  J L Reverter; M Sentí; J Rubiés-Prat; A Lucas; I Salinas; E Pizarro; J Pedro-Botet; R Romero; A Sanmartí
Journal:  Diabetes Care       Date:  1994-03       Impact factor: 19.112

Review 6.  Intracellular magnesium and insulin resistance.

Authors:  Junji Takaya; Hirohiko Higashino; Yohnosuke Kobayashi
Journal:  Magnes Res       Date:  2004-06       Impact factor: 1.115

7.  Insulin stimulates Na+, Cl-, Ca2+, and Mg2+ transports in TAL of mouse nephron: cross-potentiation with AVP.

Authors:  B Mandon; E Siga; D Chabardes; D Firsov; N Roinel; C De Rouffignac
Journal:  Am J Physiol       Date:  1993-09

8.  Magnesium dietary intake modulates blood lipid levels and atherogenesis.

Authors:  B T Altura; M Brust; S Bloom; R L Barbour; J G Stempak; B M Altura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population.

Authors:  Jiancheng Xu; Wei Xu; Hanxin Yao; Weixia Sun; Qi Zhou; Lu Cai
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: One step forward in dosing.

Authors:  Bahador Mirrahimi; Hadi Hamishehkar; Arezo Ahmadi; Mohamad Reza Mirjalili; Mostafa Aghamohamadi; Atabak Najafi; Mohammad Abdollahi; Mojtaba Mojtahedzahed
Journal:  Daru       Date:  2012-10-31       Impact factor: 3.117

View more
  6 in total

1.  Serum Magnesium Concentrations in the Canadian Population and Associations with Diabetes, Glycemic Regulation, and Insulin Resistance.

Authors:  Jesse Bertinato; Kuan Chiao Wang; Stephen Hayward
Journal:  Nutrients       Date:  2017-03-17       Impact factor: 5.717

Review 2.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

3.  Pattern of electrolyte imbalance in Type 2 diabetes patients: Experience from a tertiary care hospital.

Authors:  Rashid Naseem Khan; Farhana Saba; Syedhh Fatima Kausar; Muhammad Hassan Siddiqui
Journal:  Pak J Med Sci       Date:  2019       Impact factor: 1.088

4.  Serum magnesium in diabetic retinopathy: the association needs investigation.

Authors:  Koushik Shivakumar; A R Rajalakshmi; Kirti Nath Jha; Swathi Nagarajan; A R Srinivasan; A Lokesh Maran
Journal:  Ther Adv Ophthalmol       Date:  2021-12-05

5.  Type 2 diabetes control and complications and their relation to serum magnesium level.

Authors:  Khaled Alswat
Journal:  Arch Med Sci       Date:  2021-03-18       Impact factor: 3.318

6.  Trace elements and oxidative stress in children with type 1 diabetes mellitus.

Authors:  Ashgan Abdalla Alghobashy; Usama M Alkholy; Mohamed A Talat; Nermin Abdalmonem; Ahmed Zaki; Ihab A Ahmed; Randa H Mohamed
Journal:  Diabetes Metab Syndr Obes       Date:  2018-03-26       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.